Investors / Delin Ventures
Delin Ventures
Corporate VC
Delin Ventures is the venture arm of Delin Capital, backed by permanent capital. It invests in and builds life sciences companies, and also has technology companies and partner venture funds.
Invests inHealthcare & BiotechFintech
In its own wordslife sciencescell and gene therapydrug discoveryclinical researchmanufacturingai
Your fit with Delin Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDelin Ventures lists 12 checked portfolio companies on its own site and is named in 1 funding round, 1 of them as lead. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (56%), Fintech (19%) and Media & Entertainment (6%). 50% of its companies are based in United Kingdom. It invests most often alongside 11.2 Capital, Acadian Ventures and Accel.
Counts come from funding rounds that name Delin Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Delin Ventures' whole history. Rounds on record name 1 company; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundDelin Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 73th | 8% of companies confirmed by a round |
| Sector focus | 87th | 56% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| 11.2 Capital | 1 |
| Acadian Ventures | 1 |
| Accel | 1 |
| AlbionVC | 1 |
| Amadeus Capital Partners | 1 |
| Atlantic | 1 |
| B Capital | 1 |
| Bayer G4A | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 56% | 15% |
| Fintech | 19% | 12% |
| Media & Entertainment | 6% | 4% |
| AI & Machine Learning | 6% | 18% |
| Human Resources | 6% | 1% |
| Industrial & Manufacturing | 6% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Delin Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Delin Ventures| Date | Company | Stage |
|---|---|---|
| 1 Oct 2025 | Seed Led |
Round details for Delin Ventures
Amounts, full round histories and every co-investor in Delin Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adthera Bio provides cell and gene therapy services | Healthcare & Biotech | Portfolio page | ||
| Agile Analog delivers configurable analog IP for various applications, including security, data conversion, power management, and IC monitoring. | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Athernal Bio is developing immunotherapies for high-risk clonal haematopoiesis to address blood cancer precursor conditions | Healthcare & Biotech | Oct 2025Seed | Page + round | |
| IMMvention Therapeutix develops first-in-class BACH1 inhibitors as oral therapy for patients with sickle cell disease and other conditions. | Healthcare & Biotech | Portfolio page | ||
| LocalGlobe invests in early stage companies | Fintech | Portfolio page | ||
| Onsi combines regulated operations, configurable technology and governed AI to run claims, launch insurance propositions and deliver benefits for complex workforces. | FintechHealthcare & Biotech | Portfolio page | ||
| Ori Biotech develops and provides a platform for cell and gene therapy manufacturing | Healthcare & Biotech | Portfolio page | ||
| Penzilla automates and digitizes company pension processes for its clients | FintechHuman Resources | Portfolio page | ||
| Swarm Oncology delivers cell therapies that are highly targeted, phenotypically optimized, cost-efficient, and durable. | Healthcare & Biotech | Portfolio page | ||
| Turbine provides a virtual lab platform for biopharma discovery, allowing users to run virtual experiments and validate hypotheses | Healthcare & Biotech | Portfolio page | ||
| uMed enables faster, smarter research by connecting consented patients, verified clinical datasets and agile study design | Healthcare & Biotech | Portfolio page | ||
| Vidsy transforms enterprise brands for a new era of advertising powered by creators, technology and AI. | Media & EntertainmentAI & Machine Learning | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- delinventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 1 Oct 2025
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Delin Ventures' profile as data
Pull Delin Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/delinventures.com
# also
GET /v1/firms/delinventures.com/portfolio
GET /v1/firms/delinventures.com/coinvestors
GET /v1/firms/delinventures.com/news